Showing results (1451-1460 of 1,955) with videos related to

Sort By:
Pageof 196
Blood|July 15, 2004
Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcomeAnne J Novak, Deanna M Grote, Mary Stenson, et al.
Plos Pathogens|December 24, 2015
Plasmodium falciparum Adhesins Play an Essential Role in Signalling and Activation of Invasion into Human ErythrocytesWai-Hong Tham, Nicholas T Y Lim, Greta E Weiss, et al.
Mayo Clinic Proceedings|April 10, 2003
Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary reviewMichelle A Elliott, William L Nichols, Elizabeth A Plumhoff, et al.
Haematologica|October 14, 2011
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphomaLuis F Porrata, Kay Ristow, Joseph P Colgan, et al.
Investigational New Drugs|March 20, 2020
A phase 1 study evaluating safety and pharmacokinetics of losatuxizumab vedotin (ABBV-221), an anti-EGFR antibody-drug conjugate carrying monomethyl auristatin E, in patients with solid tumors likely to overexpress EGFRJames M Cleary, Emiliano Calvo, Victor Moreno, et al.
Bone Marrow Transplantation|April 25, 2006
Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphomaF K Buadi, I N Micallef, S M Ansell, et al.
American Journal of Clinical Pathology|June 23, 2016
Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P MutationsRebecca L King, Wilson I Gonsalves, Stephen M Ansell, et al.
BMC Medicine|May 21, 2019
Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohortsMyriam Alexander, A Katrina Loomis, Johan van der Lei, et al.
British Journal of Haematology|February 25, 2012
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphomaLuis F Porrata, Kay Ristow, Thomas M Habermann, et al.
Journal of the American College of Cardiology|December 17, 2016
Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II RegistryBenjamin A Steinberg, Peter Shrader, Laine Thomas, et al.
Pageof 196